COA/TZ-2026-050Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
Tirzepatide 5 mg
TZ-2026-050Lot TR5WT-102026Analyzed November 11, 2026
Timeline
Ordered
October 30, 2026
Received
November 10, 2026
Analyzed
November 11, 2026
Sample
Name
Tirzepatide 5 mg
Expected
Tirzepatide
Amount
3 vials (same product, conformity), lyophilized powder
Testing
Client
Bankroll Aminos
Test type
Content & purity, conformity
Method
HPLC-UV
Content, how much is in it
5.31mg
Label claim: 5 mg
Purity, how clean it is
99.3%
Average of 3 vials from the same lot, HPLC-UV peak area
Conformity
CONFORMS
All 3 vials match. Content and purity above are the average of the three. Chromatogram shows vial 1.
| Vial | Content | Purity |
|---|---|---|
| Vial 1 | 5.37 mg | 98.0% |
| Vial 2 | 5.40 mg | >99.9% |
| Vial 3 | 5.16 mg | >99.9% |
| Average | 5.31 mg | 99.3% |
Chromatogram
HPLC-UV
19.47 min, Tirzepatide, 98.0% (vial 1)
Analyst Comments
White lyophilized powder, white-cap vials, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 11, 2026
Verification Code
TZ-B8VJ-XJZV
Verify at purilab.org/verify/TZ-B8VJ-XJZV
Scan to Verify
TZ-B8VJ-XJZV
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1